Charles River Laboratories International (CRL) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Charles River Laboratories International (CRL) is Neutral.

The composite score behind that read is +0.13, weighing +0.21 of bullish evidence against -0.18 bearish.

Charles River Laboratories International last closed at $301.79, +1.27% on the session.

Against the IVW growth benchmark the position is +0.47% over the forecast window.

The read is built from 15 underlying insights — 5 bullish and 10 bearish.

Agreement across those insights is 67%.

1 graded prediction for CRL so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Charles River Laboratories International in the 33rd percentile on return on equity, where 100 is best.

Charles River Laboratories International is classified under Health Care / Life Sciences Tools & Services, with a market capitalisation of $14.23B.

StockMap tracks Charles River Laboratories International as the 11th largest of the 41 companies it covers in the Life Sciences Tools & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 37 Neutral, 2 Moderate Outperform and 2 Moderate Underperform.

On that composite Charles River Laboratories International ranks 7th of 41 in the group, against a group median of +0.06.